Pariet
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Rabeprazole (Aciphex, Alfence, Pariet) is a proton pump inhibitor (PPI) used for the treatment of adults with conditions…
Background In 2003, British Columbia’s PharmaCare programme implemented a drug reimbursement policy called Therapeutic…
A simple and sensitive HPLC method for the analysis of rabeprazole in plasma is described using UV detection in the presence of…
Total expenditure under the Community Drugs Schemes in Ireland on the proton pump inhibitors (PPI's) used for the management of…
Proton pump inhibitors have become one of the cornerstones in the treatment of Helicobacter pylori infection. Rabeprazole (Pariet…
Three groups of patients were studied with the purpose of assessing the efficiency of the application of Pariet in the complex…
The results on estimation of efficiency and safety of monotherapy by Rabeprasol in dose 20 mg per day in treatment of the…
Three groups of patients were studied with the purpose of assessing the efficiency of the application of Pariet in the complex…
UNLABELLED
Rabeprazole is an inhibitor of the gastric proton pump. It causes dose-dependent inhibition of acid secretion. In 8…
The cAMP/cAMP‐dependent protein kinase (PKA) signaling pathway has been implicated in synaptic plasticity changes and memory…